Bayer will soon include safety study summaries of glyphosate on its dedicated transparency platform. This next step will mark the first anniversary of the company’s transparency initiative, having been launched on 7 December 2017. “Our commitment to transparency remains core to our mission as we move forward as a combined company,” said Liam Condon, member of the board of management of Bayer AG and president of the Crop Science Division. “We recognise that people around the world want more information around glyphosate, and we are eager to offer access to our glyphosate-related safety data on our dedicated transparency platform. This platform has set new standards of accountability and responsibility in the sector; we pledge to use it as a springboard to continue to share science-based information with the public.” Bayer’s platform demonstrates how transparency around crop protection safety studies can help the company achieve its commitment to sound science and the safe use of its products, while at the same time maintaining confidential business information. This initiative has recently been recognised as Best Public Outreach Programme at the 2018 Agrow Awards for delivering excellence in the communication of information on the benefits of agrochemical or agbiotech products. In addition to the glyphosate study summaries which will be made available on 7 December 2018, access to the underlying safety study reports, owned by Bayer and submitted for the review that led to the European substance renewal decision in December, will be enabled next year. – Press release
German pharmaceuticals giant Bayer will provide its safety study summaries for the herbicide glyphosate on a transparency platform, in a bid to meet its "core mission" of a "commitment to transparency", said Liam Condon from the Bayer board of management. The company is also launching an online tool that allows people to see how much information they have been given about their exposure to glyphosate, and what it means for them. The glyphosate study summaries will be available from 7 December, while the underlying safety study reports will be available next year.